Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 522-529

  Sohn, Won ^a   Jun, Dae Won ^a   Kwak, Min Jung ^c   Park, Quehn ^b   Lee, Kang Nyeong ^a   Lee, Hang Lak ^a   Lee, Oh Young ^a   Yoon, Byung Chul ^a   Choi, Ho Soon ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Korean Red Cross   (South Korea)

^c PyeongTaek University   (South Korea)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Normal

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD BANK; BLOOD DONOR; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DECISION TREE; ENZYME ACTIVITY; FACTUAL DATABASE; FEMALE; HUMAN; KOREA; MALE; PRIORITY JOURNAL;

EID: 84874367732     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07143.x     Document Type: Article

References (23)

1. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin. Chem. 2000; 46: 2027-49.
2. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 2009; 49: 1859-67.
3. Shakil AO, Conry-Cantilena C, Alter HJ etal. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann. Intern. Med. 1995; 123: 330-7.
4. Tassopoulos NC. Treatment of patients with chronic hepatitis C and normal ALT levels. J. Hepatol. 1999; 31 (Suppl. 1): 193-6.
5. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983-6.
6. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-85 e11.
7. Siest G, Schiele F, Galteau MM etal. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin. Chem. 1975; 21: 1077-87.
8. Piton A, Poynard T, Imbert-Bismut F etal. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998; 27: 1213-19.
9. Dufour DR. Alanine aminotransferase: is it healthy to be "normal"? Hepatology 2009; 50: 1699-701.
10. Kariv R, Leshno M, Beth-Or A etal. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int. 2006; 26: 445-50.
11. Mohamadnejad M, Pourshams A, Malekzadeh R etal. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J. Gastroenterol. 2003; 9: 2322-4.
12. Prati D, Taioli E, Zanella A etal. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 2002; 137: 1-10.
13. Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the united states population. Hepatology 2012; 55: 447-54.
14. Kim BK, Han KH, Ahn SH. "Normal" range of alanine aminotransferase levels for Asian population. J. Gastroenterol. Hepatol. 2011; 26: 219-20.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
16. Korean National Statistical Office. 2005 Korean Population and Housing Census. 2006.
17. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
18. Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet 2002; 360: 235.
19. Kim Y, Suh YK, Choi H. BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obes. Res. 2004; 12: 445-53.
20. Kang HS, Um SH, Seo YS etal. Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population. J. Gastroenterol. Hepatol. 2011; 26: 292-9.
21. Bechtler G, Haeckel R, Horder M, Kuffer H, Porth AJ. Guidelines (1987) for classification, calculation and validation of conversion rates in clinical chemistry-International Federation of Clinical Chemistry, Scientific Committee, Analytical Section: Expert Panel on Analytical Systems, Expert Panel on Enzymes; IFCC Document Stage 2, Draft 4. J. Automat. Chem. 1987; 9: 105-12.
22. Kinoshita S, Toyofuku M, Iida H etal. Standardization of laboratory data and establishment of reference intervals in the Fukuoka Prefecture: a Japanese perspective. Clin. Chem. Lab. Med. 2001; 39: 256-62.
23. Kotani K, Maekawa M, Kanno T. [Reestimation of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio based on JSCC consensus method-changes of criteria for a differential diagnosis of hepatic disorders following the alteration from Karmen method to JSCC method.] Nihon Shokakibyo Gakkai Zasshi 1994; 91: 154-61.